Clinical Trial Update: Canadian Manufactured Tetanus and Diphtheria Toxoids Adsorbed (Td) Vaccine Compared With U.S. Manufactured Td [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating Canadian-manufactured tetanus and diphtheria toxoids adsorbed vaccine versus U.S.-manufactured Td; results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Tetanus

Drugs mentioned

• Tetanus and Diphtheria Toxoids Adsorbed (Td) Vaccine, Canadian Manufactured (Tetanus and Diphtheria Toxoids Adsorbed)
• Tetanus and Diphtheria Toxoids Adsorbed (Td) Vaccine, U.S. Manufactured (Tetanus and Diphtheria Toxoids Adsorbed)

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Diphtheria, Tetanus | Phase 4 | Status: COMPLETED | Results posted: 2011-02-18